Apollon Wealth Management’s Arcturus Therapeutics ARCT Stock Holding History

Apollon Wealth Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157K	Buy	+23,433	New	+$185K	﹤0.01%	1509

Other funds holding ARCT

Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Apollon Wealth Management's ARCT Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 23,433 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #1509 among its holdings.

20 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

Apollon Wealth Management held 23,433 shares of Arcturus Therapeutics worth $157K as of Q2 2026.
Arcturus Therapeutics was a new Apollon Wealth Management position in Q2 2026.
Arcturus Therapeutics made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1509 holding.
20 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.